Yahoo! Finance: QLTI News

Latest Financial News for QLT Inc.

• QLT shares buck falling market on buyback (AP)

  (Tue, 2 Dec 2008 00:06:28 Etc/GMT)

  Biotechnology company QLT Inc. said Monday its board of directors approved a buyback plan worth up to $50 million though a tender offer that offers investors up to a 32 percent premium.

• QLT INC/BC Files SEC form 8-K, Other Events (EDGAR Online)

  (Mon, 1 Dec 2008 18:31:40 Etc/GMT)

• QLT to repurchase up to US$ 50 million of common shares - Modified "Dutch Auction" tender offer to commence on or about December 4, 2008 (PR Newswire)

  (Mon, 1 Dec 2008 12:00:00 Etc/GMT)

• [$$] Biotech Mailbag: All About Alnylam (at RealMoney by TheStreet.com)

  (Fri, 28 Nov 2008 11:59:54 Etc/GMT)

• QLT INC/BC Financials (EDGAR Online Financials)

  (Fri, 14 Nov 2008 14:04:29 Etc/GMT)

• 'Cash Is King' Stocks (at TheStreet.com)

  (Thu, 13 Nov 2008 16:48:53 Etc/GMT)

• QLT INC/BC Files SEC form 10-Q, Quarterly Report (EDGAR Online)

  (Fri, 7 Nov 2008 20:12:55 Etc/GMT)

• [$$] This Small-Cap Biotech Holds Good Cards (at RealMoney by TheStreet.com)

  (Wed, 5 Nov 2008 16:29:59 Etc/GMT)

• QLT INC/BC Files SEC form 8-K, Other Events (EDGAR Online)

  (Thu, 30 Oct 2008 20:18:51 Etc/GMT)

• QLT Inc. Earnings Call scheduled for 8:30 am ET today (CCBN)

  (Tue, 28 Oct 2008 12:30:00 Etc/GMT)

Yahoo! Finance: QLTI Financial Blogs

Latest Financial Financial Blogs for QLT Inc.

• @VIC: A Radically Different Context for Value Was Going On Outside (at Seeking Alpha)

  (Wed, 8 Oct 2008 22:07:54 Etc/GMT)

MSN Money News - QLTI

News about QLT Inc

• Market Report -- In Play (QLTI)

  (Monday, December 01, 2008 7:05 AM)

  QLT Inc to repurchase up to US$ 50 mln of common shares - modified "Dutch Auction" tender offer to commence on or about Dec 4, 2008 Co announces that its Board of Directors has authorized management

• QLT to repurchase up to US$ 50 million of common

  (Monday, December 01, 2008 7:00 AM)

  Range of $2.20 to $2.50 per share represents a premium of 16% to 32% from

• Biotech Mailbag: All About Alnylam

  (Friday, November 28, 2008 11:50 AM)

  The stock hasn't been this low since July 2007, but lung drug data could set it up for a rebound.

• ($) Biotech Mailbag: All About Alnylam

  (Friday, November 28, 2008 6:59 AM)

  The stock hasn't been this low since July 2007, but lung drug data could set it up for a rebound.

• Beacon Equity Issues Technical Trade Alerts on Ma

  (Monday, November 10, 2008 9:00 AM)

  DALLAS, Nov. 10 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting:

QLTI - News and Analysis from Seeking Alpha

'QLTI' Tag RSS Syndication from SeekingAlpha.com

• @VIC: A Radically Different Context for Value Was Going On Outside

  (Wed, 08 Oct 2008 18:07:54 -0400)

  Phil Davis submits:

  Phil Davis attended this week's Value Investing Congress on behalf of Seeking Alpha. Here are Phil's notes from the conference.

  I was, ironically, at theValue Investing CongressTuesday where some of the best hedge fund managers in the world, such  Bill Ackman, Jeffrey Schwarz and, Leon Cooperman, to name a few share with about 1,500 investors their thoughts on the market as well as giving us overviews of their portfolios.  The investors I spoke to at the conference were definitely "shopping" as most of them...

• @VIC: Top Hedge Fund Picks

  (Tue, 07 Oct 2008 06:40:49 -0400)

  Mebane Faber submits:

  Portfolio Manager Mebane Faber attended this week's Value Investing Congresson behalf of Seeking Alpha. Here are his notes from the first day:

  While some of the most famous hedge funds are getting hammered (letters here), there are still some top investors presenting at the Value Investing Congress.If these managers liked their picks last week, they probably like them even more after the down day Monday. 

  
  Complete Story »

• QLT Inc. Q2 2008 Earnings Call Transcript

  (Wed, 20 Aug 2008 21:20:20 -0400)

  QLT Inc. (QLTI)

  Q2 2008 Earnings Call

  
  Complete Story »

• Six Canadian Life Sciences Stocks

  (Wed, 21 May 2008 08:12:41 -0400)

  Stockerblog submits:

  Last week, I wrote an article about Canadian Technology Companies. But beyond technology, mining, and oil, Canada is home to over 135 publicly traded life sciences related companies. The following Canadian stocks have market caps above $250 million, and trade either on the New York Stock Exchange or NASDAQ.

  MDS Inc. (MDZ) is an Ontario-based developer of products and services for the development of drugs, and the treatment of diseases, including pharmaceutical contract research services and contract manufacturing services for the radio therapeutics industry. The stock has a P/E of 3, and a PEG of 3.46.

  
  Complete...

• QLT: Stock up Almost 50% as RDA Removes Labeling Requirement for Aczone

  (Tue, 18 Mar 2008 05:54:14 -0400)

  FP Trading Desk submits:

  QLT Inc. (QLTI) shares were up almost 50% in Monday afternoon trading after the United States Food and Drug Administration removed a labeling requirement for Aczone, QLT's topical acne drug, that forced potential users to undergo screening and blood monitoring.

  Bob Butchofsky, president and chief executive officer of QLT said:

  We are extremely pleased to report the FDA decision to change the Aczone label as it validates QLT's clinical, regulatory and commercialization strategy for this product. Management believed in the...

• Analysts: QLT Assets Should Fetch a Healthy Premium

  (Mon, 03 Dec 2007 05:22:25 -0500)

  FP Trading Desk submits:

  QLT Inc.?s (QLTI) bid to sell its assets will likely fetch about C$7 a share, a significant premium over its current value, analysts said following the B.C. biotech company?s official announcement that its board has authorized ?exploration of strategic alternatives.?

  That announcement temporarily lifted shares to just under C$5, a 25% gain, but Raymond James analyst Brian Bapty quickly upgraded his QLT recommendation to ?outperform? from ?market perform? on the expectation that its eventual sale price will be even higher.

  
  Complete...

• Renaissance Technologies: "Black-Box" Hedge Fund Discloses New Positions

  (Tue, 13 Feb 2007 07:25:22 -0500)

  Lon Juricic submits: Renaissance Technologies disclosed a number of new 5%+ positions today in various 13G filings. Renaissance Technologies, started by Jim Simons, is considered one of the most successful hedge funds. Renaissance is a "black-box" fund, using sophisticated computer models to predict market movements.

  New 5%+ positions:

  
  Complete Story »

• Biotech Day In Review: Sanofi Loses Lovenox Patent

  (Sun, 11 Feb 2007 10:39:54 -0500)

  Sanofi-Aventis (SNY) lost a patent battle in California over its $2.5 billion anti-clotting drug, Lovenox.

  The defeat opens the battle for a generic, but that, in turn, opens up the battle of how to approve a generic version of a biologic drug, an issue that the FDA has been studiously avoiding.

  
  Complete Story »

Investor Clicks Financial Advertising

News for QLT Inc. (USA) - Google Finance

News for QLT Inc. (USA) - Google Finance

• QLT to buy back US$50 million in company shares to shore up stock price

  (Tue, 02 Dec 2008 16:46:36 GMT)
  QLT to buy back US$50 million in company shares to shore up stock price
  Business in Vancouver - Dec 2, 2008

  QLT Inc. (TSX: QLT; Nasdaq: QLTI) has announced plans to buy back US$50 million in company shares from shareholders. Under the terms of the offer, holders of the company's Nasdaq-traded stock can ...

  QLT To Buy Back US$50 Mln of shares - Update - RTT News
  QLT shares buck falling market on buyback - CNNMoney.com
  Lethbridge Herald

• BCE, Crystallex, Ensign, QLT, Uranium One: Canada Stock Preview

  (Mon, 01 Dec 2008 13:54:36 GMT)
  BCE, Crystallex, Ensign, QLT, Uranium One: Canada Stock Preview
  Bloomberg - Dec 1, 2008

  By John Kipphoff Dec. 1 (Bloomberg) -- The following companies may have unusual price changes in Canadian trading today. Stock symbols are in parentheses, and share prices are from the close on ...

• Market Report -- In Play (QLTI)

  (Mon, 01 Dec 2008 13:16:59 GMT)
  Market Report -- In Play (QLTI)
  MSN Money - Dec 1, 2008

  QLT Inc to repurchase up to US$ 50 mln of common shares - modified "Dutch Auction" tender offer to commence on or about Dec 4, 2008 Co announces that its Board of Directors has authorized ...

• QLT to repurchase up to US$ 50 million of common shares - Modified "Dutch Auction" tender offer to commence on or about December 4, 2008

  (Mon, 01 Dec 2008 12:03:30 GMT)
  QLT to repurchase up to US$ 50 million of common shares - Modified "Dutch Auction" tender offer to commence on or about December 4, 2008
  Canada NewsWire (press release) - Dec 1, 2008

  << Range of $2.20 to $2.50 per share represents a premium of 16% to 32% from previous day's closing price >> VANCOUVER, Dec. 1 /CNW/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) announced that its Board of ...

  QLT Inc. (QLTI) Announces $50M Dutch Tender Offer - StreetInsider.com (subscription)
  

• Learn about the World Ophthalmic Pharmaceutical Drugs Market

  (Tue, 25 Nov 2008 11:16:08 GMT)
  Learn about the World Ophthalmic Pharmaceutical Drugs Market
  MarketWatch - Nov 25, 2008

  NEW YORK, Nov 25, 2008 (BUSINESS WIRE) -- Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue. This report ...

• QLT Inc. (NASDAQ:QLTI) - Visudyne sales prospects remains weak, however, strong cash supports optimism. Free research report for 3Q 08 results.

  (Mon, 24 Nov 2008 15:57:45 GMT)
  QLT Inc. (NASDAQ:QLTI) - Visudyne sales prospects remains weak, however, strong cash supports optimism. Free research report for 3Q 08 results.
  Research Oracle - Nov 24, 2008

  QLT Inc (QLT) reported significant yoy decline in sales in 3Q 08, primarily attributable to declining sales of Visudyne. Total sales were below our expectations in 3Q 08. Going forward, we expect ...

• QLT Inc - Premium Company Profile - New Research Report on Companies and Markets

  (Fri, 14 Nov 2008 21:22:58 GMT)
  QLT Inc - Premium Company Profile - New Research Report on Companies and Markets
  Live-PR.com (Pressemitteilung) - Nov 14, 2008

  QLT was originally focused on discovering, developing and commercializing innovative therapies in the fields of ophthalmology and dermatology. In 2006, the company changed its focus to purely ...

• Technical Trade Alert on Market Movers: INCY, QLTI, LINTA, PDGI, FRPT, SVNT

  (Mon, 10 Nov 2008 15:52:50 GMT)
  Technical Trade Alert on Market Movers: INCY, QLTI, LINTA, PDGI, FRPT, SVNT
  Baystreet.ca - Nov 10, 2008

  DALLAS, Texas ? Beacon Equity Research announces the release of Trade Alerts covering market movers: Incyte Corp. (Nasdaq: INCY), QLT Inc. (Nasdaq: QLTI), Liberty Media Interactive (Nasdaq: LINTA ...

• Beacon Equity Issues Technical Trade Alerts on Market Movers: INCY, QLTI, LINTA, PDGI, FRPT, SVNT

  (Mon, 10 Nov 2008 14:10:14 GMT)
  Beacon Equity Issues Technical Trade Alerts on Market Movers: INCY, QLTI, LINTA, PDGI, FRPT, SVNT
  CNNMoney.com (press release) - Nov 10, 2008

  DALLAS, Nov. 10 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Today?s Trade Alerts include: Incyte Corp. (Nasdaq: INCY), QLT Inc. (Nasdaq ...

• QLT Announces 2008 Third Quarter Results

  (Sat, 01 Nov 2008 10:30:54 GMT)
  QLT Announces 2008 Third Quarter Results
  HULIQ (press release) - Nov 1, 2008

  QLT Inc. (NASDAQ: QLTI; TSX: QLT) reported financial results for the third quarter ended September 30, 2008. Unless specified otherwise, all amounts are in US dollars and in accordance with US ...

MarketWatch.com - All MarketWatch News - QLTI

MarketWatch, a leading publisher of business and financial news, offers users up-to-the minute news, investment tools, and subscription products.

• Reckitt Benckiser in licensing deal with QLT over Atrigel

  (Tue, 26 Aug 2008 02:38:04 -0500)

  LONDON (MarketWatch) -- Reckitt Benckiser Pharmaceuticals on Tuesday said it has signed an exclusive licensing agreement with QLT, Inc. subsidiary QLT USA for its Atrigel sustained-release drug delivery technology, except for certain rights being retained by QLT USA and its prior licensees. Under the terms of the deal QLT USA will receive an upfront total payment of $25 million and may receive potential milestone payments of up to $5 million based on the successful development of two Atrigel-formulated products.

• Reckitt Benckiser in licensing deal with QLT for Atrigel

  (Tue, 26 Aug 2008 02:07:59 -0500)

• Movers & Shakers: Monday's biggest gaining and declining stocks

  (Mon, 09 Jun 2008 16:39:00 -0500)

  Among the companies whose shares are seeing active trade in Monday’s session are Lehman Brothers, Apple and Texas Instruments.

• Allergan to acquire Aczone Gel from QLT for $150 mln

  (Mon, 09 Jun 2008 07:04:28 -0500)

• Movers & Shakers: Friday's biggest gaining and declining stocks

  (Fri, 18 Jan 2008 15:03:00 -0500)

  Among the companies whose shares are expected to see active trade in Friday's session are AMD, GE, GM, Inspire Pharma, IBM, Johnson Controls, LaBranche, Performance Food, QLT, Schlumberger, Sprint Nextel, Tiffany, TI, Washington Mutual and Wilmington Trust.

• Indications: Dow futures up 250 points on central bank actions

  (Wed, 12 Dec 2007 09:27:00 -0500)

  NEW YORK (MarketWatch) -- U.S. stock futures implied a surge at Wednesday's start after the Federal Reserve announced steps to improve liquidity and encourage lending between banks.

• Movers & Shakers: Wednesday's biggest gaining and declining stocks

  (Wed, 28 Nov 2007 16:26:00 -0500)

  SAN FRANCISCO (MarketWatch) -- Shares of the following companies were among those making 5% or more percentage moves in the U.S. stock market Wednesday.

• Biotech Stocks: Drug stocks climb; Abbott up modestly ahead of FDA meeting

  (Wed, 28 Nov 2007 13:14:00 -0500)

  BOSTON (MarketWatch) -- Drug and biotech stocks added to gains Wednesday as shares of QLT Inc. soared on a company announcement that it's looking to sell some or all of its assets.

• QLT to seek buyers for all or part of company

  (Wed, 28 Nov 2007 09:25:49 -0500)

  BOSTON (MarketWatch) -- Biopharmaceutical developer QTL Inc. said early Wednesday that its board has authorized the formation of a special committee to seek out potentials buyers for some or all of its assets. "The board of directors believes that the net value of the assets of the company exceeds the value represented by the stock price," QLT Chairman Boyd Clarke said in a statement. "We had hoped to address that disconnect through the deployment of our current strategic plan. However, as the gap continues to widen we have decided that, other than as contractually required, making significant additional investments...

• QLT: District court adopts Nov 2006 court decision

  (Tue, 10 Jul 2007 15:11:42 -0500)

Only registered users can write comments.
Please login or register.

---